M ental health monitoring has often relied on measures of structure and process to assess compliance with strategy or policy. [1] [2] [3] However, structure and process are only indirect measures of improved health outcomes, the ultimate concern of patients, families, clinicians, and decision makers. Unfortunately, many outcome measures developed for research studies are less suitable for routine practice in that they are neither comprehensive nor easy to use. 1, 4 Among mental health outcome measures that have been developed for routine use, most information concerns the HoNOS. The HoNOS instrument has been validated in the United Kingdom, Europe, and Australia. [5] [6] [7] [8] There are 3 versions that cover all ages: children and adolescents (HoNOSCA), working-age adults (HoNOS), and people aged 65 years and older (HoNOS65+). [8] [9] [10] The structure of the latter 2 is the same except for relatively minor differences in their accompanying glossaries. 6, 11 We describe the 2 forms as the adult version in our paper. Field trials of this instrument indicate that it is simple to use, applicable to a wide range of psychotic and nonpsychotic disorders, comprehensive of clinical and social functioning, acceptable to clinicians, sensitive to change, and reliable in studies in the United Kingdom and Australia. 10 Training and follow-up sessions are required to ensure reliability and fidelity of ratings. 7 Among other available instruments, quality of life measures such as the Short Form 12 or 36 are well validated but are intended for use in a wide range of settings, rather than mental health specifically. They are therefore too generic or too long. The Global Assessment of Function is familiar to mental health clinicians but only gives a single score without subscores for behaviour, impairment, symptoms, and social functioning. Other instruments such as the General Health Questionnaire, Hospital Anxiety and Depression Schedule, Hamilton Depression Rating Scale, or Brief Psychiatric Rating Scale are too long or specific to particular diagnoses. Unlike HoNOS, they have not been designed for routine clinical use. Finally, HoNOS is available at little cost from the copyright holder.
The adult version of HoNOS has 12 items (13 in the case of HoNOSCA) and 4 sections: behaviours, impairments, symptoms, and social functioning. 6, 11, 12 The adult version has an item for other symptoms in which symptoms other than delusions, hallucinations, or depression are recorded. 6, 11 HoNOSCA has 2 additional items on knowledge of presenting difficulties or potential services (Section B). However, these items do not contribute to the total score. 9, 12 Each scale is scored 0 to 4 with a total score of 48 (52 in the case of HoNOSCA). A higher score indicates greater morbidity. The HoNOS takes 5 minutes to complete following a clinical interview.
Although it was designed to measure outcome, most research has been on the instrument's cross-sectional features such as reliability, criterion and concurrent validity rather than its longitudinal properties such as sensitivity to change or predictive validity. 13 However, measurement of outcome implies assessment over time to measure response to interventions. In addition, the psychometrics of HoNOS have usually been assessed in specifically designed studies rather than being measured in routine clinical use. Finally, HoNOS has not been widely used in North America.
There have only been 2 Canadian studies of the French and English versions, respectively. [14] [15] [16] As elsewhere, concurrent validity was highest for the total score and following formal training in its use. Use of a tabulated glossary and feedback of clinically useful information improved clinician support and completion rates for the routine measurement of health outcomes with HoNOS. 16 Importantly, it was possible to combine the glossaries of the HoNOS and the HoNOS65+ versions to produce a single adult version glossary while preserving the psychometrics of the original instrument. 15, 16 However, both Canadian studies focused on cross-sectional data. Evidence for sensitivity was more limited, possibly related to the relatively low numbers of patients available for follow-up. 15 Neither study considered the predictive validity of HoNOS in terms of subsequent health service use.
Method

Data Sources and Setting
The study was carried out in the outpatient facilities of AVDHA and SSDHA, Nova Scotia. SSDHA was one of the sites of an earlier pilot project evaluating the psychometric properties of HoNOS in a North American setting. 15, 16 All clinical staff were trained in use of HoNOS and HoNOS65+; clinicians specializing in youth services received further training in HoNOSCA. 9, 12 Initial training in Nova Scotia was conducted by one of the authors who had completed HoNOS training at the Royal College of Psychiatrists in London, England. ICC for the overall global score at the end of training were good (0.96, P = 0.001). ICC scores for the subsections were lower, but still significant. 15 HoNOS assessments were also to be completed on patients whose care episode exceeded 12 months. Data were entered using the routine administrative data system of the province (the MHOIS). Clinicians attached HoNOS scores to the MHOIS returns routinely submitted on each patient visit. Collected data were used to give participating clinicians feedback in the form of summary statistics on their patients' scores. We used the change of score between the beginning of each care episode and the final assessment to assess sensitivity.
We were unable to assess predictive validity in our previous study because of the short follow-up. 15 The longer duration of this study enabled us to assess the association between initial HoNOS score and subsequent service use over the following year as captured by the following routine administrative databases of Nova Scotia and held by the Population Health Research Unit at Dalhousie University:
The physician billings database covers all fee-for-service claims under the provincial health care plan, including date of service, ICD-9 diagnoses, and patient demographics. In Canada, all visits to family physicians and psychiatrists in the community are billed directly to the health care plan of each province.
The CIHI discharge abstract database covers admission and separation times, ICD-9 and ICD-10 diagnoses, and patient demographics.
The MHOIS contains information on demographic characteristics, diagnoses and care episodes with allied health professionals as well as psychologists and psychiatrists. Unlike the 2 previous sources of data, the Department of Health stopped province-wide collection of MHOIS data in 2006.
We used the administrative data for the whole province to ensure all health services activity was captured in case patients were seen, or admitted, elsewhere in Nova Scotia, other than the District Health Authority of residence. The Dalhousie University Research Ethics Board reviewed and passed the study protocol.
Statistical Analysis
We assessed sensitivity to change using the paired sample t test for both global scores and each item. We repeated our analysis for individual scale items using equivalent nonparametric statistics (the Wilcoxon rank sum test), as we could not assume with 100% certainty that HoNOS had an underlying interval scale. Lack of symmetry and constant variance can also undermine the validity of parametric tests, especially when sample sizes are small. For each item we also assessed change from the presence of symptomatology (that is a mild, moderate, or severe problem of clinical significance as indicated by scores of 2, 3, and 4, respectively) to minimal symptomatology requiring no action (scores of 0 and 1, respectively). We again tested significance using Wilcoxon signed rank tests.
We assessed predictive validity by measuring the association between baseline HoNOS score (continuous and in dichotomized about the median with HoNOS caseness defined as patients in the upper 50%) and the following outcomes: admissions and bed days both in psychiatric and in nonpsychiatric units, and MHOIS, GP, and psychiatrist visits. The follow-up period for patients was 1 year after the initial HoNOS assessment. We used negative binomial regression to adjust for potential confounders such as sociodemographic characteristics, psychiatric diagnosis, and health service use in the year prior to entry into the study. We restricted the analysis of predictive validity to patients who had both a lead-in and a follow-up of 1 year. Where data were skewed, we used Winsorizing to set outliers to the 98% percentile.
We also examined time to psychiatric admission in the year following initial HoNOS assessment using Kaplan-Meier survival and Cox regression analyses. Initially, we used Kaplan-Meier survival analysis to compare the risks of admission between high and low HoNOS scores. The survival function was generated using the actuarial method by dividing the time period into 365 days. We defined censored cases as being cases in which the person did not require psychiatric hospital admission during the course of the study. Readmission periods were calculated in daily observations from the index date. We compared the survival curves using the log-rank test. We then performed a Cox regression analysis to adjust for potential confounders.
Results
Baseline Data
The total number of patients in the sample was 5620. Among these, 2644 patients (47.0%) came from the AVDHA and 2976 patients (53.0%) came from the SSDHA.
Among the 5620 patients, 4620 in the sample received at least one valid HoNOS or HoNOSCA assessment, giving a completion rate of 82.2%. However, many of these patients visited a mental health service clinic only once during the data collection period; their case files were therefore both opened and closed on the day of their HoNOS assessment. Patients who only had 1 service visit were therefore removed from further HoNOS analyses. Once this had been done, 4305 valid assessments at baseline remained.
The average age of the 4305 patients in the sample was 36.9 years (SD 21.9) and 2344 (54.4%) were female. The 4 most common specific diagnostic categories were as follows: depressive disorders (19.0%), adjustment reactions (15.7%), neurotic and somatoform disorders (15.3%), and developmental and disruptive disorders (10.1%). Nearly 74% of patients were rated using the adult version (n = 3177), the remaining 1128 using the child and adolescent version.
The average age of the 3177 adult patients was 45.9 years (SD 18.5) and 59.7% were female (n = 1898). The mean HoNOS score was 10.0 (SD 5.5) and nearly one-quarter of adults were diagnosed with depressive disorders (23.8%, n = 756).
Among the 1128 children in the sample, 60.5% were male (n = 682). The average age of patients was 11.7 years (SD 4.0). The most common specific diagnosis in children was developmental or disruptive disorders (n = 363, 32.2%) and the mean HoNOSCA score was 11.0 (SD 5.2).
Sensitivity to Change
During the study period, 2735 patients were discharged from care. A further 489 completed 1 year of treatment. This gave a total of 3224 patients who were potentially eligible for a follow-up HoNOS. Among patients discharged from care, 1569 patients failed to attend for follow-up, moved out of the district, or died. As we were assessing the number of patients who should have had a HoNOS completed by staff, not the number who did not attend subsequent appointments, this left 1655 patients who should have had a follow-up HoNOS assessment. Among these patients, 808 (49%) received a follow-up.
There were 599 adults who had at least one follow-up HoNOS assessment. The average time between the baseline and final HoNOS assessment was 264 days (SD 224). There were significant changes both in the global score and in 9 out of the 12 items covering a wide range of behaviours, impairments, symptoms, and social functioning ( Table 1 ). The only exceptions were problem drinking or drug taking, problems with living conditions, and problems with occupations or activities. We found the same results using Wilcoxon rank sum tests on each pair of scores.
There were 209 children or youth who had at least one follow-up HoNOSCA assessment. The average time between the baseline and final HoNOSCA assessment was 296 days (SD 215). For HoNOSCA, there were significant changes both in the global score and in 8 out of the 13 items including: aggression, overactivity, nonaccidental self-injury, nonorganic somatic symptoms, emotional disorders, problems with relationships or family life, and school (Table 1) . We found the same results using Wilcoxon rank sum tests on each pair of scores.
We found similar results when we assessed change from the presence of symptomatology to none or minimal symptomatology using Wilcoxon sign rank test. The only exception was that the change in cognition was no longer significant in the adult version, as was the change in nonorganic somatic symptoms in HoNOSCA.
Predictive Validity
We restricted the analysis of predictive validity to patients who had both a lead-in and a follow-up of 1 year (n = 1359). . Table 2 shows the association between baseline HoNOS score and outcomes. We ran separate analyses for each outcome. In each case, there were 1359 patients apart from the MHOIS data where there were only 446 patients. The HoNOS score showed a significant association with health service use apart from visits to psychiatrists that were billed to the province where the result was not significant.
We used the deviance divided by the degrees of freedom to assess the fit of the negative binomial models. Ratios were all below 1.2, indicating a good fit for each model. After adjusting for confounders, the baseline HoNOS score was significantly associated with all indicators of subsequent in and outpatient service use, except for billed visits to psychiatrists where there was a negative relation ( Table 2 ). We found similar results for the dichotomized HoNOS score, except that the findings for the MHOIS data were no longer significant (Table 3 ).
Survival analyses indicated that patients in the highest 50% of dichotomized HoNOS scores were significantly more likely to be admitted over the following year than those in the lowest 50% (log-rank c 2 = 39.3, df = 1, P < 0.001) ( Figure 1) . The Cox regression analysis revealed an adjusted hazard ratio of 1.9 per unit increase of HoNOS score during the same period (95%CI 1.6 to 2.1).
Discussion
Strengths
Canada has advantages for assessing the use of HoNOS in routine clinical care that are not available elsewhere. Under the Canada Health Act, all Canadian residents are entitled to in or outpatient care that is free at the point of delivery.
Patients receive treatment at publicly funded facilities or are seen by private psychiatrists or GPs in the community who bill the provincial health plan. Health service use can therefore be tracked across an entire jurisdiction using routinely collected clinical data, in contrast to studies where outcomes are assessed in specific field trials, 5, 7 or for a discrete service, program, or network. [17] [18] [19] [20] Further studies of the routine use of HoNOS in specific programs have still relied on stand-alone data capture rather than existing administrative databases for the entire health service. [17] [18] [19] [20] Most studies have also examined the concurrent properties of HoNOS rather than the sensitivity or predictive validity, 13 and there are limited data from Canada. [14] [15] [16] In addition, previous studies have evaluated the use of each form of the HoNOS in isolation, 13 which may have limited applicability to the introduction of all 3 forms at the same time. By contrast, this study evaluated the longitudinal properties of HoNOS across all age groups in a way that resembled normal clinical practice as much as possible. No research workers were involved in the collection, capture, or entry of the data. This study is also one of few that have examined the predictive validity of the instrument, and the first to have demonstrated it in a Canadian setting. In addition, this is the only study to have studied both the sensitivity and the predictive validity of the instrument when used with the combined adult glossary that covered both HoNOS and HoNOS65+ versions.
Sensitivity to Change
In terms of sensitivity to change in outpatient settings, this study (n = 808) was considerably larger than a previous pilot (n = 288). 15 The smaller study was only able to demonstrate sensitivity for the total score and 4 out of the 12 adult items and 5 out of 13 HoNOSCA items. With greater numbers, we were able to show changes in 9 out of the 12 adult version items and 8 of the 13 HoNOSCA items. Improvement over time was most evident for the total score but was also seen for a wide range of behaviours, impairments, symptoms, and social functioning, especially for the adult version.
Our findings for the adult version are consistent with findings from previous studies where changes in global score are more consistent than those of the subscores. An interaction between setting, diagnosis, and severity has been suggested. 13 HoNOS may be better able to detect change in patients with higher baseline HoNOS scores, adults aged 65 years and older, inpatients, and general adult outpatients with depression or anxiety. 13, [17] [18] [19] By contrast, the instrument appeared less useful for detecting change in psychotherapy outpatients. 20 Our findings for HoNOSCA were more modest but still showed significant changes in spite of the smaller numbers. They reflect results from Great Britain where change in HoNOSCA scores was greatest in items measuring symptoms and behaviours, rather than social and impairment scales. 12
Predictive Validity
As in studies elsewhere of the HoNOS, we found that the instrument showed good predictive validity in terms of service contacts, lengths of stay and readmission rates, and retention in the community with high levels of significance. 13 There were 2 exceptions: increased HoNOS scores were either not associated, or negatively associated, with billed visits to psychiatrists. Given that our sample were patients of publicly provided mental health services, this may reflect relative lack of flow between publicly and privately provided care. Alternatively, it may mean that patients with less severe symptoms can be managed by office-based psychiatrists who bill the province rather than a publicly funded mental health team. Second, while continuous HoNOS score predicted mental health outpatient visits, the dichotomized score did not. This possibly reflects reduced statistical power, given the lower numbers for this outcome (n = 446), compared with the others (n = 1359).
There have been even fewer predictive validity studies of the other versions. 13 We are unaware of any studies of the HoNOS65+ and only 1 of the HoNOSCA. 13 As in our work, the 1 study of HoNOSCA showed that total scores at community assessment were associated with subsequent health service use. 13
Limitations
This study has several limitations. Although 82% of eligible patients had a HoNOS rating at baseline, this fell to only 49% of the follow-up assessments. These may have biased the results on sensitivity to change. Conversely, the results on predictive validity used routine administrative datasets of health service use and therefore were less subject to follow-up bias. However, these data may be subject to recording bias and have limited information on sociodemographic factors. The data for one of our outcomes, MHOIS visits, were only available for 446 patients as the Department of Health stopped collecting province-wide MHOIS data in 2006. This also means that the mechanism for routinely collecting these data is no longer available. Lastly, although Spanish and French versions are available, our results may not be generalizable to other North American settings because of differences in sociodemographic and health service characteristics.
Implications
Given the widespread routine use of HoNOS in Great Britain, Australia, and New Zealand, a common outcome measure would enable comparisons between jurisdictions of illness severity and outcomes. Aside from Nova Scotia, there is interest in HoNOS from Quebec, Alberta, and British Columbia. By 2010, HoNOS will be routinely used in major centres in Alberta. In contrast to the Great Britain, where there is generally separate training for the 3 forms of HoNOS, the experience in Nova Scotia suggests that clinicians can complete the same core workshop. This workshop is supplemented by additional training, which is more specific to the adult or HoNOSCA versions.
For clinicians, the value of HoNOS lies in measuring change across the 4 sections of the instrument, as well as the individual item scores. International experience suggests that the success of routine outcome measurement depends, to a critical degree, on the engagement of clinicians who actually complete the outcome measures. 21 Engagement is most likely to occur when clinicians are given meaningful information that enables reflective practice and improves patient care. 21 For policy-makers, total scores can be used to measure the clinical acuity of people presenting for services, as well as their progress over time.
In conclusion, HoNOS has satisfactory sensitivity and predictive validity for routine use in one Canadian setting, even though this may not necessarily generalize to others. We could introduce the adult version and HoNOSCA simultaneously and collect data using routine databases. The instrument is comprehensive, applicable across the lifespan, and available at little cost from the copyright holder for use in publicly funded health facilities.
Résumé : Les échelles adultes et enfants / adolescents Health of the Nation Outcome Scales mesurent-elles les résultats?
Objectif : Parmi les mesures des résultats de la santé mentale qui ont été mises au point pour un usage courant, les Health of the Nation Outcome Scales (HoNOS) ressortent particulierement. Cet instrument est largement utilisé en Europe, en Australie, et en Nouvelle-Zélande, mais pas au Canada. Nous en avons testé la sensibilité et la validité prédictive dans des conditions ressemblant le plus fidèlement possible à un usage courant.
Méthode : On a demandé à des cliniciens traitants d'évaluer les patients de tous âges adressés à des établissements externes de santé mentale de 2 districts sanitaires de la Nouvelle-Écosse à l'aide soit de HoNOS pour adultes, soit de HoNOS pour enfants et adolescents (HoNOSCA). Les données ont été entrées au moyen du système courant existant de données administratives.
Résultats : Nous avons obtenu au moins 1 notation sur 4 620 patients, équivalant à un taux de réponse de 82 %. Au suivi, les notations pour le score global et la plupart des items individuels étaient sensibles au changement (n = 808). Après ajustement pour les variables confondantes, un score de départ à l'HoNOS était significativement associé à une utilisation subséquente des services internes et externes, notamment les hospitalisations, les durées de séjour, et les contacts psychiatriques (n = 1 359).
Conclusions : L'HoNOS présentait une sensibilité et une validité prédictive satisfaisantes pour un usage courant. Nous pourrions introduire la version pour adultes et l'HoNOSCA pour les enfants / adolescents simultanément, et recueillir des données à l'aide des bases de données actuelles. Étant donné l'usage courant répandu d'HoNOS internationalement, l'utilisation de la même mesure des résultats au Canada permettrait de comparer la gravité et les résultats de la maladie entre territoires.
